156 related articles for article (PubMed ID: 29869258)
1. Drug-Loaded Plant-Virus Based Nanoparticles for Cancer Drug Delivery.
Bruckman MA; Czapar AE; Steinmetz NF
Methods Mol Biol; 2018; 1776():425-436. PubMed ID: 29869258
[TBL] [Abstract][Full Text] [Related]
2. Tobacco mosaic virus-based protein nanoparticles and nanorods for chemotherapy delivery targeting breast cancer.
Bruckman MA; Czapar AE; VanMeter A; Randolph LN; Steinmetz NF
J Control Release; 2016 Jun; 231():103-13. PubMed ID: 26941034
[TBL] [Abstract][Full Text] [Related]
3. Featured Article: Delivery of chemotherapeutic vcMMAE using tobacco mosaic virus nanoparticles.
Kernan DL; Wen AM; Pitek AS; Steinmetz NF
Exp Biol Med (Maywood); 2017 Aug; 242(14):1405-1411. PubMed ID: 28675044
[TBL] [Abstract][Full Text] [Related]
4. Viral nanoparticles for in vivo tumor imaging.
Wen AM; Lee KL; Yildiz I; Bruckman MA; Shukla S; Steinmetz NF
J Vis Exp; 2012 Nov; (69):e4352. PubMed ID: 23183850
[TBL] [Abstract][Full Text] [Related]
5. Cancer Theranostic Applications of Albumin-Coated Tobacco Mosaic Virus Nanoparticles.
Pitek AS; Hu H; Shukla S; Steinmetz NF
ACS Appl Mater Interfaces; 2018 Nov; 10(46):39468-39477. PubMed ID: 30403330
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice.
Bruckman MA; Randolph LN; VanMeter A; Hern S; Shoffstall AJ; Taurog RE; Steinmetz NF
Virology; 2014 Jan; 449():163-73. PubMed ID: 24418549
[TBL] [Abstract][Full Text] [Related]
7. Elongated Plant Virus-Based Nanoparticles for Enhanced Delivery of Thrombolytic Therapies.
Pitek AS; Wang Y; Gulati S; Gao H; Stewart PL; Simon DI; Steinmetz NF
Mol Pharm; 2017 Nov; 14(11):3815-3823. PubMed ID: 28881141
[TBL] [Abstract][Full Text] [Related]
8. Bioinspired Artificial Tobacco Mosaic Virus with Combined Oncolytic Properties to Completely Destroy Multidrug-Resistant Cancer.
Wu H; Zhong D; Zhang Z; Li Y; Zhang X; Li Y; Zhang Z; Xu X; Yang J; Gu Z
Adv Mater; 2020 Mar; 32(9):e1904958. PubMed ID: 31961987
[TBL] [Abstract][Full Text] [Related]
9. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
Elbialy NS; Fathy MM; Khalil WM
Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
[TBL] [Abstract][Full Text] [Related]
11. Chemical modification of the inner and outer surfaces of Tobacco Mosaic Virus (TMV).
Bruckman MA; Steinmetz NF
Methods Mol Biol; 2014; 1108():173-85. PubMed ID: 24243249
[TBL] [Abstract][Full Text] [Related]
12. Functionalized silk spheres selectively and effectively deliver a cytotoxic drug to targeted cancer cells in vivo.
Florczak A; Deptuch T; Lewandowska A; Penderecka K; Kramer E; Marszalek A; Mackiewicz A; Dams-Kozlowska H
J Nanobiotechnology; 2020 Dec; 18(1):177. PubMed ID: 33261651
[TBL] [Abstract][Full Text] [Related]
13. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
14. Bioinspired Silica Mineralization on Viral Templates.
Dickmeis C; Altintoprak K; van Rijn P; Wege C; Commandeur U
Methods Mol Biol; 2018; 1776():337-362. PubMed ID: 29869253
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery and pH-responsive release of doxorubicin to cancer cells using calcium carbonate/hyaluronate/glutamate mesoporous hollow spheres.
Guo Y; Li H; Shi W; Zhang J; Feng J; Yang X; Wang K; Zhang H; Yang L
J Colloid Interface Sci; 2017 Sep; 502():59-66. PubMed ID: 28477470
[TBL] [Abstract][Full Text] [Related]
16. Boron Nitride Nanoparticles with a Petal-Like Surface as Anticancer Drug-Delivery Systems.
Sukhorukova IV; Zhitnyak IY; Kovalskii AM; Matveev AT; Lebedev OI; Li X; Gloushankova NA; Golberg D; Shtansky DV
ACS Appl Mater Interfaces; 2015 Aug; 7(31):17217-25. PubMed ID: 26192448
[TBL] [Abstract][Full Text] [Related]
17. pH-Triggered Surface Charge Reversed Nanoparticle with Active Targeting To Enhance the Antitumor Activity of Doxorubicin.
Du JB; Cheng Y; Teng ZH; Huan ML; Liu M; Cui H; Zhang BL; Zhou SY
Mol Pharm; 2016 May; 13(5):1711-22. PubMed ID: 26998644
[TBL] [Abstract][Full Text] [Related]
18. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
[TBL] [Abstract][Full Text] [Related]
19. Mesoporous γ-Iron Oxide Nanoparticles for Magnetically Triggered Release of Doxorubicin and Hyperthermia Treatment.
Benyettou F; Ocadiz Flores JA; Ravaux F; Rezgui R; Jouiad M; Nehme SI; Parsapur RK; Olsen JC; Selvam P; Trabolsi A
Chemistry; 2016 Nov; 22(47):17020-17028. PubMed ID: 27739116
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
